Line 19: | Line 19: | ||
<a href="https://2021.igem.org/Team:GreatBay_SCIE" style="padding-right:0px"> | <a href="https://2021.igem.org/Team:GreatBay_SCIE" style="padding-right:0px"> | ||
− | <img class="plogo" id="project_logo" src="https://static.igem.org/mediawiki/2021/6/6a/T--GreatBay_SCIE--Project_Logo.png" alt="logo" height="46" | + | <img class="plogo" id="project_logo" src="https://static.igem.org/mediawiki/2021/6/6a/T--GreatBay_SCIE--Project_Logo.png" alt="logo" height="46" style="position:absolute; margin-left:50px; margin-top:10px; left:0px;"> |
− | + | <img class="tlogo" id="team_logo" src="https://static.igem.org/mediawiki/2021/0/06/T--GreatBay_SCIE--Team_Logo.png" alt="logo" height="46" style="position:absolute; left:0; margin-top:13px!important; left:0px;"> | |
− | <img class="tlogo" id="team_logo" src="https://static.igem.org/mediawiki/2021/0/06/T--GreatBay_SCIE--Team_Logo.png" alt="logo" height="46" style="position:absolute; left:0; margin-top:13px!important;"> | + | |
</a> | </a> | ||
− | + | <ul style="margin-left: -11px"> | |
− | <ul style="margin | + | |
<li> | <li> | ||
<a href="https://2021.igem.org/Team:GreatBay_SCIE">Home</a> | <a href="https://2021.igem.org/Team:GreatBay_SCIE">Home</a> | ||
Line 68: | Line 66: | ||
<li><a href="https://2021.igem.org/Team:GreatBay_SCIE/Optimum_Aptamer_Concentration" >Optimum Liposome-Aptamer Ratio</a></li> | <li><a href="https://2021.igem.org/Team:GreatBay_SCIE/Optimum_Aptamer_Concentration" >Optimum Liposome-Aptamer Ratio</a></li> | ||
<li><a href="https://2021.igem.org/Team:GreatBay_SCIE/Drug_Loading">Drug Loading</a></li> | <li><a href="https://2021.igem.org/Team:GreatBay_SCIE/Drug_Loading">Drug Loading</a></li> | ||
− | <li><a href="https://2021.igem.org/Team:GreatBay_SCIE/Dissociation_constant"> | + | <li><a href="https://2021.igem.org/Team:GreatBay_SCIE/Dissociation_constant">Dissociation Constant</a></li> |
<li><a href="https://2021.igem.org/Team:GreatBay_SCIE/3D_Model">3D Models</a></li> | <li><a href="https://2021.igem.org/Team:GreatBay_SCIE/3D_Model">3D Models</a></li> | ||
Revision as of 11:50, 21 October 2021
![](https://static.igem.org/mediawiki/2021/7/74/T--GreatBay_SCIE--loading.gif)
![](https://static.igem.org/mediawiki/2021/2/23/T--GreatBay_SCIE--Head1.png)
![](https://static.igem.org/mediawiki/2021/7/7c/T--GreatBay_SCIE--Head.png)
![](https://static.igem.org/mediawiki/2021/d/df/T--GreatBay_SCIE--OCK.png)
![](https://static.igem.org/mediawiki/2021/5/53/T--GreatBay_SCIE--Main_Transition_1.png)
![](https://static.igem.org/mediawiki/2021/a/ac/T--GreatBay_SCIE--Head3.png)
![](https://static.igem.org/mediawiki/2021/9/9e/T--GreatBay_SCIE--Transition_3.png)
-
TEAM
GreatBay_SCIE consists of 15 enthusiastic and imaginative students, who aim to apply synthetic biology in real life.
-
PROJECT
We design an improved ligand-nanoparticle system which utilizes pH-sensitive aptamer to improve specificity on targeting HER2 proteins.
-
LAB
Our lab is made up of three main parts: aptamer experiment, nanoparticles manufacturing & modification, and cell cultivation & experiments, of which results verified the availability and prospect of our system.
-
MODEL
We design two specific models which collect datas from both our experiments and published theses to calculate and predict the best conditions for our system.
-
HP
Through contacting professors, doctors, and public service organizations, we not only receive useful advice for our methods and experiments but also understand patients' feelings and know their needs.
![](https://static.igem.org/mediawiki/2021/d/da/T--GreatBay_SCIE--Bottom_Banner.png)